The closure of a Teva Pharmaceuticals manufacturing plant in Irvine, Calif., could affect the availability of 24 generic sterile injectable drugs, including five essential medicines, according to the first analysis from the End Drug Shortages Alliance.
Read the full post on Becker's Hospital Review - Healthcare News
